SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 34.35 |
| Enterprise Value ($M) | 49.48 |
| Book Value ($M) | -8.73 |
| Book Value / Share | -1.04 |
| Price / Book | -3.93 |
| NCAV ($M) | -24.27 |
| NCAV / Share | -2.87 |
| Price / NCAV | -1.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.49 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -1.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.22 |
| Current Ratio | 1.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26.94 |
| Assets | 42.47 |
| Liabilities | 51.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Kingdon Capital Management, L.l.c. | 1.50 | -73.97 | |
| 13G | Satterfield Thomas A Jr | 8.05 | ||
| 13G/A | Maverick Capital Ltd | 9.90 | -89.52 | |
| 13G | M28 Capital Management LP | 7.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 18,216 | 107,697 | 16.91 | |
| 13,574 | 85,014 | 15.97 | |
| 12,748 | 58,322 | 21.86 | |
| 11,470 | 49,996 | 22.94 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPRX – Catalyst Pharmaceuticals, Inc. | CRBP – Corbus Pharmaceuticals Holdings, Inc. |
| CRDF – Cardiff Oncology, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. |